All Peaks Capital

All Peaks Capital is an AI-driven fund whose officers, per its SEC Form ADV, include Andrew Einhorn, Brett, and Enrique Orozco.

All Peaks Capital operates on an evergreen basis, meaning it does not raise funds from outside limited partners with a fixed 10-year cycle. This permanent capital structure allows the firm to hold investments indefinitely, add to public-market positions after a portfolio company IPOs, and avoid forced selling during market downturns. The strategy relies on a concentrated number of high-conviction bets rather than a broad index approach.

The firm focuses primarily on biotechnology and technology companies. In biotech, it often participates in early-stage financings for companies still in preclinical or early clinical trial phases. It has maintained significant, long-term public equity positions in biotech firms such as Zymeworks and ESSA Pharma. The firm looks for science-driven founders and is comfortable with the binary risk inherent in drug development.

All Peaks Capital functions as the investment vehicle for the Douglas family's own capital. It is not registered as an investment adviser for outside clients in the traditional sense. The firm's structure as an evergreen, single-family-backed entity gives it operational flexibility that a registered fund manager typically does not have.

Yes. The Douglas Foundation operates alongside the investment activities. Founded by Kevin Douglas and his wife, the foundation channels resources into scientific research, medical advancement, and environmental conservation. The close proximity of the foundation and the investment office means that certain capital allocation decisions can be informed by the family's long-term scientific and philanthropic goals.